I agree that this site is using cookies. You can find further informations here.
X
Muchtar, E
129  results:
Search for persons X
?
1

Correction: Outcomes among newly diagnosed AL amyloidosis p..:

Vaxman, I. ; Kumar, S. K. ; Buadi, F....
Leukemia.  38 (2024)  8 - p. 1866-1866 , 2024
Link: https://doi.org/10.1038/..
 
?
2

Daratumumab, carfilzomib, and pomalidomide for the treatmen..:

Vaxman, I. ; Kumar, S. K. ; Buadi, F....
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
3

Predictive Value of high-sensitivity cardiac troponin T in ..:

De Michieli, L ; Abouezzeddine, O F ; Abbasi, M A...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
4

P884: POTENTIAL BENEFIT OF POST-TRANSPLANT DOXYCYCLINE IN A..:

Abdallah, N. ; Dispenzieri, A. ; Muchtar, E....
HemaSphere.  6 (2022)  - p. 776-777 , 2022
Link: https://doi.org/10.1097/..
 
?
5

P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB..:

Vaxman, I. ; Kumar, S. ; buadi, F....
HemaSphere.  6 (2022)  - p. 856-857 , 2022
Link: https://doi.org/10.1097/..
 
?
6

P656: INCIDENT VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WIT..:

Koehler, A. ; Moise, M. ; Call, T....
HemaSphere.  6 (2022)  - p. 554-555 , 2022
Link: https://doi.org/10.1097/..
 
?
7

Outcomes among newly diagnosed AL amyloidosis patients with..:

Vaxman, I. ; Kumar, S. K. ; Buadi, F....
Leukemia.  35 (2021)  12 - p. 3604-3607 , 2021
Link: https://doi.org/10.1038/..
 
?
8

"Real-life" data of the efficacy and safety of belantamab m..:

Vaxman, I. ; Abeykoon, J. ; Dispenzieri, A....
Blood Cancer Journal.  11 (2021)  12 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
9

Systemic amyloidosis from A (AA) to T (ATTR): a review:

Muchtar, E. ; Dispenzieri, A. ; Magen, H....
Journal of Internal Medicine.  289 (2020)  3 - p. 268-292 , 2020
Link: https://doi.org/10.1111/..
 
?
10

Outcomes of maintenance therapy with lenalidomide or bortez..:

Chakraborty, R ; Muchtar, E ; Kumar, S K...
Leukemia.  32 (2017)  3 - p. 712-718 , 2017
Link: https://doi.org/10.1038/..
 
?
11

Revisiting conditioning dose in newly diagnosed light chain..:

Tandon, N ; Muchtar, E ; Sidana, S...
Bone Marrow Transplantation.  52 (2017)  8 - p. 1126-1132 , 2017
Link: https://doi.org/10.1038/..
 
?
12

Prevalence and predictors of thyroid functional abnormaliti..:

Muchtar, E. ; Dean, D. S. ; Dispenzieri, A....
Journal of Internal Medicine.  281 (2017)  6 - p. 611-619 , 2017
Link: https://doi.org/10.1111/..
 
?
13

Unravelling hypothyroidism in AL amyloidosis: Authors' repl:

Muchtar, E. ; Gertz, M. A.
Journal of Internal Medicine.  283 (2017)  1 - p. 108-108 , 2017
Link: https://doi.org/10.1111/..
 
?
14

Elevated pre-transplant C-reactive protein identifies a hig..:

Chakraborty, R ; Muchtar, E ; Kumar, S K...
Bone Marrow Transplantation.  53 (2017)  2 - p. 155-161 , 2017
Link: https://doi.org/10.1038/..
 
?
15

Immunoparesis in newly diagnosed AL amyloidosis is a marker..:

Muchtar, E ; Dispenzieri, A ; Kumar, S K...
Leukemia.  31 (2016)  1 - p. 92-99 , 2016
Link: https://doi.org/10.1038/..
 
1-15